2.50
Hdl Handle:
http://hdl.handle.net/2336/251472
Title:
Árangur kransæðahjáveituaðgerða á Íslandi 2002­2006
Other Titles:
Outcome of myocardial revascularisation in Iceland
Authors:
Hannes Sigurjónsson; Sólveig Helgadóttir; Sæmundur J. Oddsson; Martin Ingi Sigurđsson; Arnar Geirsson; Þórarinn Arnórsson; Tómas Guðbjartsson
Citation:
Læknablaðið 2012, 98(9):451-6
Issue Date:
Sep-2012
Abstract:
In Iceland over 3500 coronary artery bypass operations have been performed, both On-Pump, using cardiopulmonary bypass and Off-Pump, surgery on a beating heart. The aim was to study their outcome. This was a retrospective study on 720 consecutive patients who underwent surgical revascularisation at Landspítali-The National University Hospital of Iceland between 2002-2006; 513 On-Pump and 207 Off-Pump patients. Complications and operative mortality (<30 days) were compared between the groups and predictors of survival identified using multivariate analysis. The number of males was significantly higher in the On-Pump group, but other risk factors of coronary artery disease, including age and high body mass index, were comparable, as were the number of distal anastomoses and EuroSCORE. The Off-Pump procedure took 25 minutes longer on average and chest tube output was significantly increased, but the amount of transfusions administered was similar. The rate of minor complications was higher in the On-Pump group. Of the major complications, stroke rates were similar in both groups (2%) but the rate of reoperation for bleeding was higher in the On-Pump group. Mean length of hospital stay was one day longer for On-Pump patients but operative mortality was similar for both groups (4% vs. 3%, p=0.68) as was 5 year survival (92% in both groups). In multivariate analysis both EuroSCORE and age predicted outcome of operative mortality and long term survival but type of surgery (On-Pump vs. Off-Pump) was not a predictive variant. Outcome of myocardial revascularisation in Iceland is good as regards operative mortality and long term survival. This applies to both conventional On-Pump and Off-Pump procedures.; Inngangur: Á Íslandi hafa verið framkvæmdar um 3500 kransæðahjáveituaðgerðir, annað hvort með hjarta- og lungnavél (HLV) eða á sláandi hjarta (SH). Tilgangur rannsóknarinnar var að kanna árangur þessara aðgerða hér á landi. Efniviður og aðferðir: Rannsóknin var afturskyggn og náði til 720 sjúklinga sem gengust undir kransæðahjáveituaðgerð á Landspítala árin 2002-2006 og skiptust þeir í tvo hópa; 513 einstaklinga sem gengust undir aðgerð með HLV (HLV-hópur) og 207 á SH (SH-hópur). Fylgikvillar og dánartíðni innan 30 daga voru borin saman milli hópa og forspárþættir lifunar metnir með ein- og fjölbreytugreiningu. Niðurstöður: Karlar voru fleiri í HLV-hópi en áhættuþættir kransæðasjúkdóma, aldur og líkamsþyngdarstuðull reyndust sambærilegir milli hópa, einnig fjöldi æðatenginga og EuroSCORE. Aðgerðir á sláandi hjarta stóðu 25 mínútum lengur og blæðing í brjóstholskera var marktækt aukin en magn blóðs sem var gefið var sambærilegt í báðum hópum. Minniháttar fylgikvillar voru algengari í HLV-hópi (58% á móti 48%, p<0,05). Af alvarlegum fylgikvillum voru enduraðgerðir vegna blæðinga algengari í HLV-hópi og heildarlegutími rúmum sólarhring lengri. Dánartíðni innan 30 daga var hins vegar áþekk í báðum hópum (4% á móti 3%, p=0,68), einnig 5 ára lifun sem var í kringum 93% í báðum hópum. Í fjölbreytugreiningu spáðu hærra EuroSCORE og aldur fyrir dánartíðni innan 30 daga og langtímalifun en ekki tegund aðgerðar (HLV eða SH). Ályktanir: Árangur kransæðahjáveituaðgerða á Íslandi er góður, bæði hvað varðar dánartíðni innan 30 daga og langtímalifun. Þetta á jafnt við um aðgerðir sem framkvæmdar eru með aðstoð HLV og á sláandi hjarta.
Description:
Neðst á síðunni er hægt að nálgast greinina í heild sinni með því að smella á hlekkinn View/Open Allur texti - Full text
Additional Links:
http://www.laeknabladid.is

Full metadata record

DC FieldValue Language
dc.contributor.authorHannes Sigurjónssonen_GB
dc.contributor.authorSólveig Helgadóttiren_GB
dc.contributor.authorSæmundur J. Oddssonen_GB
dc.contributor.authorMartin Ingi Sigurđssonen_GB
dc.contributor.authorArnar Geirssonen_GB
dc.contributor.authorÞórarinn Arnórssonen_GB
dc.contributor.authorTómas Guðbjartssonen_GB
dc.date.accessioned2012-11-08T14:03:02Z-
dc.date.available2012-11-08T14:03:02Z-
dc.date.issued2012-09-
dc.date.submitted2012-11-08-
dc.identifier.citationLæknablaðið 2012, 98(9):451-6en_GB
dc.identifier.issn0023-7213-
dc.identifier.pmid22947627-
dc.identifier.urihttp://hdl.handle.net/2336/251472-
dc.descriptionNeðst á síðunni er hægt að nálgast greinina í heild sinni með því að smella á hlekkinn View/Open Allur texti - Full texten_GB
dc.description.abstractIn Iceland over 3500 coronary artery bypass operations have been performed, both On-Pump, using cardiopulmonary bypass and Off-Pump, surgery on a beating heart. The aim was to study their outcome. This was a retrospective study on 720 consecutive patients who underwent surgical revascularisation at Landspítali-The National University Hospital of Iceland between 2002-2006; 513 On-Pump and 207 Off-Pump patients. Complications and operative mortality (<30 days) were compared between the groups and predictors of survival identified using multivariate analysis. The number of males was significantly higher in the On-Pump group, but other risk factors of coronary artery disease, including age and high body mass index, were comparable, as were the number of distal anastomoses and EuroSCORE. The Off-Pump procedure took 25 minutes longer on average and chest tube output was significantly increased, but the amount of transfusions administered was similar. The rate of minor complications was higher in the On-Pump group. Of the major complications, stroke rates were similar in both groups (2%) but the rate of reoperation for bleeding was higher in the On-Pump group. Mean length of hospital stay was one day longer for On-Pump patients but operative mortality was similar for both groups (4% vs. 3%, p=0.68) as was 5 year survival (92% in both groups). In multivariate analysis both EuroSCORE and age predicted outcome of operative mortality and long term survival but type of surgery (On-Pump vs. Off-Pump) was not a predictive variant. Outcome of myocardial revascularisation in Iceland is good as regards operative mortality and long term survival. This applies to both conventional On-Pump and Off-Pump procedures.en_GB
dc.description.abstractInngangur: Á Íslandi hafa verið framkvæmdar um 3500 kransæðahjáveituaðgerðir, annað hvort með hjarta- og lungnavél (HLV) eða á sláandi hjarta (SH). Tilgangur rannsóknarinnar var að kanna árangur þessara aðgerða hér á landi. Efniviður og aðferðir: Rannsóknin var afturskyggn og náði til 720 sjúklinga sem gengust undir kransæðahjáveituaðgerð á Landspítala árin 2002-2006 og skiptust þeir í tvo hópa; 513 einstaklinga sem gengust undir aðgerð með HLV (HLV-hópur) og 207 á SH (SH-hópur). Fylgikvillar og dánartíðni innan 30 daga voru borin saman milli hópa og forspárþættir lifunar metnir með ein- og fjölbreytugreiningu. Niðurstöður: Karlar voru fleiri í HLV-hópi en áhættuþættir kransæðasjúkdóma, aldur og líkamsþyngdarstuðull reyndust sambærilegir milli hópa, einnig fjöldi æðatenginga og EuroSCORE. Aðgerðir á sláandi hjarta stóðu 25 mínútum lengur og blæðing í brjóstholskera var marktækt aukin en magn blóðs sem var gefið var sambærilegt í báðum hópum. Minniháttar fylgikvillar voru algengari í HLV-hópi (58% á móti 48%, p<0,05). Af alvarlegum fylgikvillum voru enduraðgerðir vegna blæðinga algengari í HLV-hópi og heildarlegutími rúmum sólarhring lengri. Dánartíðni innan 30 daga var hins vegar áþekk í báðum hópum (4% á móti 3%, p=0,68), einnig 5 ára lifun sem var í kringum 93% í báðum hópum. Í fjölbreytugreiningu spáðu hærra EuroSCORE og aldur fyrir dánartíðni innan 30 daga og langtímalifun en ekki tegund aðgerðar (HLV eða SH). Ályktanir: Árangur kransæðahjáveituaðgerða á Íslandi er góður, bæði hvað varðar dánartíðni innan 30 daga og langtímalifun. Þetta á jafnt við um aðgerðir sem framkvæmdar eru með aðstoð HLV og á sláandi hjarta.en_GB
dc.languageice-
dc.language.isoisen
dc.publisherLæknafélag Íslands, Læknafélag Reykjavíkuren_GB
dc.relation.urlhttp://www.laeknabladid.isen_GB
dc.rightsArchived with thanks to Læknablađiđen_GB
dc.subjectHjartalækningaren_GB
dc.subjectHjartasjúkdómaren_GB
dc.subjectKransæðasjúkdómaren_GB
dc.subject.meshCoronary Artery Bypassen_GB
dc.subject.meshCoronary Artery Bypass, Off-Pumpen_GB
dc.subject.meshCoronary Artery Diseaseen_GB
dc.subject.meshFemaleen_GB
dc.subject.meshHospitals, Universityen_GB
dc.subject.meshHumansen_GB
dc.subject.meshIcelanden_GB
dc.subject.meshLength of Stayen_GB
dc.subject.meshMaleen_GB
dc.subject.meshMultivariate Analysisen_GB
dc.subject.meshOutcome and Process Assessment (Health Care)en_GB
dc.subject.meshPostoperative Complicationsen_GB
dc.subject.meshQuality Indicators, Health Careen_GB
dc.subject.meshReoperationen_GB
dc.subject.meshRetrospective Studiesen_GB
dc.subject.meshRisk Assessmenten_GB
dc.subject.meshRisk Factorsen_GB
dc.subject.meshSurvival Analysisen_GB
dc.subject.meshTime Factorsen_GB
dc.subject.meshTreatment Outcomeen_GB
dc.titleÁrangur kransæðahjáveituaðgerða á Íslandi 2002­2006is
dc.title.alternativeOutcome of myocardial revascularisation in Icelanden_GB
dc.typeArticleen
dc.contributor.departmentDepartment of Cardiothoracic Surgery, Landspítala-The National University Hospital of Iceland, Faculty of Medicine, University of Iceland, Reykjavik, Iceland.en_GB
dc.identifier.journalLæknablaðiðen_GB
dc.rights.accessOpen Access - Opinn aðganguren
dc.type.categoryHjartaskurðlækningaren_GB

Related articles on PubMed

All Items in Hirsla are protected by copyright, with all rights reserved, unless otherwise indicated.